Otherwise, high serum levels of CD112 correlated with clinical stage, tumor size and metastatic status, but was not considered a significant predictor of progression-free survival in lung cancer [22], probably derived from its weak interaction with TIGIT [23]. This evidence concerns the gene NECTIN2 and lung cancer.